Get notified when GRML files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (worsened) — Going concern warning persists while accumulated deficit doubled from $10.6M to $21.1M, indicating deteriorating financial condition despite improved near-term liquidity.
- Material Weakness (unchanged) — Material weaknesses in internal controls persist unchanged from prior year, attributed to inadequate accounting resources and lack of segregation of duties.
Greenland Mines pivots to critical minerals mining, raises $13M amid 4x share dilution
Filed April 1, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read
Key Changes
-
high
Company acquired Greenland Mines Corp. in March 2026 and changed name from Klotho Neurosciences to Greenland Mines Ltd, pivoting from pharmaceutical development to critical minerals mining. Net loss increased 72% to $10.6M as operating cash burn doubled to $5.9M.
Business & MD&A verify on EDGAR → -
high
Outstanding shares surged from 28M to 121M (4x dilution) as company raised $13M through stock sales, convertible notes, and at-the-market offerings to fund operations and acquisition. Accumulated deficit doubled from $10.6M to $21.1M.
Risk Factors & MD&A verify on EDGAR → -
high
Nasdaq granted extension until September 14, 2026 to regain $1 minimum bid price compliance; delisting risk remains if stock fails to trade above $1 for 10 consecutive days by deadline.
Risk Factors verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.
Partner
Trade GRML commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 4:13 PM